Policy Articles

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies
A. Rajan, A. Berns, U. Ringborg, J. Celis, B. Ponder, C. Caldas, D. Livingston, R. G. Bristow, T. T. Hecht, T. Tursz, H. van Luenen, P. Bono, T. Helander, K. Seamon, J. F. Smyth, D. Louvard, A. Eggermont and W. H. van Harten
Volume 10, Issue 5, May 2016

Cancer Core Europe: A first step towards a virtual cancer institute in Europe?
J. Celis and U. Ringborg
Volume 8, Issue 7, October 2014

Shaping science policy in Europe
J. Celis and J. Gago
Volume 8, Issue 3, May 2014

Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer community
R. Sullivan
Volume 3, Issue 3, June 2009

Trends in the global funding and activity of cancer research
S. Eckhouse, G. Lewison and R. Sullivan
Volume 2, Issue 1, June 2009

The Stockholm Declaration
U. Ringborg
Volume 2, Issue 1, June 2008

Cancer research in the UK: A policy review of the junior academic clinical faculty
R. Sullivan
Volume 1, Issue 4, April 2008

News

From January 1, 2017 Molecular Oncology is published by FEBS Press and Wiley

Molecular Oncology has become fully Open Access, allowing everyone to read the journal irrespective of speciality, host institution or location. All articles are published under the Creative Commons Attribution License (CC BY) to meet funders’ requirements worldwide.

Citation Metrics

  • 2015 2-Year Impact Factor: 5.367
  • 2015 5-Year Impact Factor: 6.08
  • 2016 CiteScore: 5.25

Editorial Board

Editor-in-Chief Julio Celis

Senior Associate Editors Anne-Lise Børresen-Dale and  Ulrik Ringborg 

Managing Editor Jose Moreira

Future Events in Oncology

06 - 09 September, 2017, Mainz/Frankfurt, Germany
08 - 12 September, 2017, Madrid, Spain
05 - 06 October, 2017, Buenos Aires, Argentina
13 - 14 October, 2017, Zürich, Switzerland
24 - 27 November, 2017, Milan, Italy
02 - 05 December, 2017, Florida, USA
05 - 09 December, 2017, Texas, USA